“Pharmacotherapeutic follow-up in patients with type 1 diabetes in context of judicialization: possibility optimize costs”, Braz. J. Pharm. Sci., vol. 59, p. e23264, Nov. 2023, doi: 10.1590/s2175-97902023e23264.